Jacob et al. (2007) reported impairment in the expression of EAAT1 and EAAT2 at both gene and protein levels in the hippocampus and gyrus frontalis medialis of AD patients, but up-regulation in the cerebellum. Here, SLC1A2 is linked to Alzheimer disease.